MaQxan™ S51 is a scientifically engineered marigold extract standardised to a precise 5:1 Lutein-to-Zeaxanthin ratio, tailored for beauty-from-within applications. It is manufactured by Ingex Botanicals (P) Limited, India, the manufacturing arm of Ingex Germany GmbH, and supplied to nutricosmetic and wellness brands across Europe.
In today’s environment, skin faces constant assault — beyond UV, chronic blue light from screens and environmental pollutants accelerate “inflamm-aging.” MaQxan™ S51 acts as an internal shield: it scavenges free radicals and helps modulate inflammatory pathways (IL-6, COX-2, MMP-9) that degrade skin integrity.
As Lutein and Zeaxanthin are highly lipophilic, MaQxan™ S51 uses advanced in-house technology for water-dispersibility — enabling faster absorption, superior bioavailability and easy incorporation into gummies, beverages, soft gels and more.

Everything you need to know about this clinically proven nutricosmetic ingredient: origin, the 5:1 advantage, clinical proof, and formats.
Derived from marigold (Tagetes erecta) via a backward-integrated, ethanol-only supply chain with full seed-to-shelf traceability.
A precise 5:1 Lutein-to-Zeaxanthin ratio rendered water-dispersible for faster absorption and superior bioavailability in beauty formats.
A randomised, double-blind, placebo-controlled study showed +6.18% elasticity, +22.64% collagen and −29.20% TEWL at day 84.
100% solar-powered manufacturing, HPLC-verified, fully tested for PA, PAH and pesticides for the European market.
Water-dispersible delivery technology, clinically proven dermal restructuring, dual UV + blue-light defence, and 100% solar manufacturing.
Superior Bioavailability
Faster absorption and easy beauty-format integrationClinically Proven
+22.64% collagen intensity over 84 daysUV + Blue Light
Protects against UV-induced and digital stressScope 3 & CSRD Ready
Supports your corporate sustainability goalsFrom clinically proven dermal restructuring and water-dispersible technology to Rotterdam warehouse stock and full EU compliance, MaQxan™ S51 is built for European beauty and wellness brands.
Generic antioxidants often fail to provide the structural support skin needs. MaQxan™ S51 doesn’t just mask aging — it neutralises free radicals and helps inhibit the inflammatory pathways (IL-6, COX-2, MMP-9) that degrade skin integrity.
Engineered for stability and sensory performance, it is the foundation for next-generation, science-led functional beauty supplements.
Eliminate the long international shipping wait. We hold ready stock in our Rotterdam warehouse for rapid, de-risked EU distribution within 48–72 hours.
Get a QuoteMaQxan™ S51 is supplied in versatile, formulation-ready beauty formats. Recommended use: 20 mg Lutein + 4 mg Zeaxanthin (5:1) daily. Engineered for stability and scalability in beauty applications.
| Grade / Form | Standardisation | Typical Application |
|---|---|---|
| Direct-Compression Granules | 5:1 Lutein : Zeaxanthin by HPLC | High-stability tablets and capsules |
| Water-Dispersible Powder | 5:1 L:Z, 20% WD by HPLC | Beverages, gummies, dairy, sachets |
| Beadlets | 5:1 L:Z by HPLC | Beauty gummies and premixes |
| Oil Suspension | 5:1 L:Z, ultra-refined sunflower oil | Soft gels and high-bioavailability formats |
| Custom Grade | Available on Request | Bespoke to customer formulation requirements |
Custom specifications can be developed on request. Contact us for certificates of analysis, safety data sheets, and technical documentation.
MaQxan™ S51 is backed by an 84-day randomised, double-blind, placebo-controlled clinical study demonstrating measurable dermal restructuring.
CTRI/2025/05/087675 · Randomised, double-blind, placebo-controlled study
The study enrolled 90 healthy volunteers (aged 18–60) over an 84-day protocol with oral supplementation of the 5:1 Lutein-to-Zeaxanthin ratio.
At day 84, supplementation produced statistically significant improvements: +6.18% skin elasticity, +22.64% collagen intensity and a −29.20% reduction in TEWL (trans-epidermal water loss).
Mechanistically, MaQxan™ S51 reduces IL-6, COX-2 and MMP-9 markers, inhibits the AP-1 pathway and modulates TRPA1 — preserving dermal structure through potent ROS scavenging.
Request Clinical DossierCommon questions from European nutricosmetic and wellness brands about MaQxan™ S51 Lutein & Zeaxanthin.
Request a sample, bulk quote, clinical dossier or technical documentation for MaQxan™ S51 nutricosmetic Lutein & Zeaxanthin. Our team responds within one business day.
Or write to us at: enquiry@ingexgermany.de